Investigation of DNA topoisomerase I as an autoantigen at the thyroid cancer

Biopolymers and Cell

Volumn 17, Issue 6, 2001, Pages 551-555

  Sidorik, L L ^a   Rybkinska, T A ^a   Vigontina, O G ^a   Vudmaska, M I ^a   Naidenov, V G ^a   Pogribnyi, P V ^b   Lisovskii, I L ^b   Schvachko, L P ^a   Bronstein, I ^c   Lyzogubov, V V ^d   Prihod'ko, E A ^d   Usenko, V S ^d   Matsuka, G Kh ^a  

^a INSTITUTE OF MOLECULAR BIOLOGY AND GENETICS   (Ukraine)

^b R E KAVETSKY INSTITUTE OF EXPERIMENTAL PATHOLOGY   (Ukraine)

^c UNIVERSITY OF YORK   (United Kingdom)

^d Pathomorphological Laboratory 'BIONTEK'   (Ukraine)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0012364619     PISSN: 02337657     EISSN: 19936842     Source Type: Journal    
DOI: 10.7124/bc.0005DF     Document Type: Article

References (20)

1. Pommier Y, Pourquier P., Fan Y, Strumberg D. Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme (Review) // Biochim. et biophys. acta.-1998.-N 1400.-P. 83-106.
2. Capranico G., Binaschi M. DNA sequence selectivity of topoisomerases and topoisomerase poisons // Biochim. et biophys. acta.-1998.-N 1400.-P. 185-194.
3. Froelich-Ammon S. J., Osheroff N. Topoisomerase poisons: Harnessing the dark side of enzyme mechanism // J. Biol. Chem.-1995.-270, N 37.-P. 21429-21432.
4. Redinbo M. R, Stewart L, Champoux J. J., Hoi W. G. J. Structural flexibility in human topoisomerase I revealed in multiple non-isomorphous crystal structures // J. Mol. Biol.-1999.-292.-P. 685-696.
5. Shew J. H, Bordwell B., Rothfield N. F., Earnshaw W. C. High titers of autoantibodies to topoisomerase I (Scl-70) in sera from scleroderma patients // Science.--1986.-231.-P. 737-740.
6. Guldner H. H., Szostecki C, Vosberg H. P., Lakomek H. J., Penner E., Batz F. A. Scl-70 autoantibodies from scleroderma patients recognize a 95 kDa protein identified as DNATopoisomerase I // Chromosoma.-1986.-94, N 2.-P. 132-138.
7. Johanet C, Agostini M. M., Vayssairat M., AbuafN. Anti-Scl-70 and anticentromere autoantibodies. Biological markers of 2 forms of systemic scleroderma // Press Med.-1989.-18, N 5.-P. 207-211.
8. Koto T., Yamamoto JC, Takeuchi H., Obebo M., Hara E., Nakada S., Oda IC, I to 1C, Nishioka IC Identification of an universal B-cell epitope on DNA Topoisomerase I, an autoantigen associated with scleroderma // Arth. Rheum.-1993.-36, N 11.-P. 1580-1587.
9. Parmiani G. Tumor immunity as autoimmunity: tumor antigens include normal self proteins which stimulate anergic peripheral T cells // Immunol. Today.-1993.-14, N 11.-P. 536-538.
10. Kyndt X., Habbar M., Querel V, Hachulla K, Hatron P. Y., Devulder B. Systemic scleroderma and cancer. Search for predictive factors of cancer in 123 patients with scleroderma // Rev. Med. Int.-1997.-18, N 7.-P. 528-532.
11. Laemmli U. 1C Cleavage of structural proteins during the assembly of the bacteriophage T4 // Nature.-1970.-227, N 5.-P. 680-685.
12. Bradford M. M. A rapid and sensitive method for quantitation of microgramm quantities of protein utilizing the principle of dye binding // Anal. Biochem.-1976.-72, N 3.-P. 248-254.
13. Duguet M., Lavenon C, Harper F., Mirambeau G., De-Recondo A.-M. DNA topoisomerases from rat liver: physiological variations // Nucl. Acids Res.-1983.-11, N 3.-P. 1056-1075.
14. Castora F. J., Kelly W. ATP inhibits nuclear and mitochondrial type I topoisomerases from human leukemia cells // Proc. Nat. Acad. Sci. (USA).-1986.-83, N 6.-P. 1680-1684.
15. Matsiota P., Druet P., Dasquet P. Natural autoantibodies in systemic lupus erythematosus // Clin. Exp. Immunol.-1987.-69, N 4.-P. 79-88.
16. De Rooij D. J., Van de Putte L B., Habets W. Verbek A. L., Van Venrooij W. J. The use of immunoblotting to detect antibodies to nuclear and cytoplasmic antigens. Clinical and serological associations in rheumatic diseases // Scand. J. Rheumatol.-1988.-17, N 5.-P. 353-364.
17. Sidorik L L, Gudzera O. I., Dragovoz K A, Tukalo M. A., Beresten S. F. Immunochemical non-cross-reactivity between eukaryotic and prokaryotic seryl-tRNA synthetases // FEBS Lett.-1991.-292, N 1, 2.-P. 76-78.
18. Moll I. W., Hooijkaas R., Van Goorbergh B. C, Roos L. G., Henzen-Logmans S. C, Vecht C. I. Systemic and antineuronal autoantibodies in patients with paraneoplastic neurological disease // J. Neurol.-1996.-243, N 1.-P. 51-56.
19. Kuwana M., Fujii T., Mimori T., Kaburaki J. Enhancement of anti-DNA topoisomerase I antibodies response after lung cancer in patients with systemic sclerosis. A report of two cases // Arth. Rheum.-1996.-39, N 4.-P. 686-691.
20. Popazov G., Baleva R., Chavrakov G., Mendizov E. Case of Hashimoto's toxicosis with occult thyroid carcinoma // Vutr. Bol.-1981.-20, N 5.-P. 105-117.